Cargando…

Clinical study on postoperative triple-negative breast cancer with Chinese medicine: Study protocol for an observational cohort trial

BACKGROUND: Breast cancer (BC) poses a tremendous threat to the health of women worldwide, especially triple-negative breast cancers (TNBCs). Currently, the curative effect of traditional Chinese medicine (TCM) has been recognized in more and more people worldwide; however, the specific effect has n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiajing, Qin, Yuenong, Sun, Chenping, Hao, Wei, Zhang, Shuai, Wang, Yi, Chen, Juan, Chen, Lixin, Ruan, Yiying, Liu, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023942/ https://www.ncbi.nlm.nih.gov/pubmed/29923998 http://dx.doi.org/10.1097/MD.0000000000011061

Ejemplares similares

Sanyin Formula Enhances the Therapeutic Efficacy of Paclitaxel in Triple-Negative Breast Cancer Metastases through the JAK/STAT3 Pathway in Mice
por: Wu, Chunyu, et al.
Publicado: (2022)

Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial
por: Hao, Wei, et al.
Publicado: (2017)

Effectiveness of the Sanyin Formula Plus Chemotherapy on Survival in Women With Triple-Negative Breast Cancer: A Randomized Controlled Trial
por: Wu, Chunyu, et al.
Publicado: (2022)

Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway
por: Li, Feifei, et al.
Publicado: (2022)

Tongue features of patients with granulomatous lobular mastitis
por: Chen, Jiajing, et al.
Publicado: (2022)

Relationship between Acute Mastitis and Constitution of Traditional Chinese Medicine in Chinese Breastfeeding Mothers
por: Bao, Yijia, et al.
Publicado: (2021)

Platycodon grandiflorum Protects Against Anthracycline-Induced Cardiotoxicity in Early Breast Cancer Patients
por: Hao, Wei, et al.
Publicado: (2020)

Extract of Platycodon grandiflorum Prevents Doxorubicin-induced Cardiotoxicity in Breast Cancer
por: Shi, Youyang, et al.
Publicado: (2023)

Treatment of triple-negative breast cancer with Chinese herbal medicine: A prospective cohort study protocol
por: Meng, Hui, et al.
Publicado: (2017)

Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
por: Zhao, Wenjie, et al.
Publicado: (2021)

Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women
por: Hao, Shuang, et al.
Publicado: (2015)

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
por: Shao, Zhiying, et al.
Publicado: (2016)

Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Huang, Yunxia, et al.
Publicado: (2023)

Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms
por: Yeh, Shan-Ju, et al.
Publicado: (2021)

Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women
por: Chen, Hong-liang, et al.
Publicado: (2016)

Phrenic nerve block combined with stellate ganglion block for postoperative intractable hiccups: a case report
por: Zhong, Yubin, et al.
Publicado: (2023)

Identify the triple-negative and non-triple-negative breast cancer by using texture features of medicale ultrasonic image: A STROBE-compliant study
por: Chen, Qingyu, et al.
Publicado: (2021)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
por: Gonçalves, Homero, et al.
Publicado: (2018)

Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery
por: Lin, Wei-Xun, et al.
Publicado: (2022)

Combination of Chinese medicinal formulas and chemotherapy for triple-negative breast cancer strengthens body resistance to eliminate pathogenic factors
por: Zhang, Yiyi, et al.
Publicado: (2022)

Targeted Chinese Medicine Delivery by A New Family of Biodegradable Pseudo-Protein Nanoparticles for Treating Triple-Negative Breast Cancer: In Vitro and In Vivo Study
por: Kwan, Hiu Yee, et al.
Publicado: (2021)

The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
por: Fan, Yiqi, et al.
Publicado: (2022)

Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy
por: He, Xi, et al.
Publicado: (2018)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Prospective observational pharmacogenetic study of side effects induced by intravenous morphine for postoperative analgesia
por: Chen, Li-Kuei, et al.
Publicado: (2017)

Triple negative breast carcinoma is a prognostic factor in Taiwanese women
por: Lin, Che, et al.
Publicado: (2009)

The expression of androgen receptor in triple-negative breast cancer and the effect of a traditional Chinese medicine formula on disease-free survival
por: Yu, Linghong, et al.
Publicado: (2022)

Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer
por: Yao, Qian, et al.
Publicado: (2022)

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
por: Xiao, Yi, et al.
Publicado: (2022)

Clinical outcomes of influenza-like illness treated with Chinese herbal medicine: an observational study
por: Xiaoyan, Li, et al.
Publicado: (2018)

Application of Traditional Chinese Medicines in Postoperative Abdominal Adhesion
por: Wu, Fuling, et al.
Publicado: (2020)

Nanomaterial Technology and Triple Negative Breast Cancer
por: Hou, Kai, et al.
Publicado: (2022)

Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy
por: Bayoumi, Yasser, et al.
Publicado: (2014)

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast
por: Kuroda, Hajime, et al.
Publicado: (2021)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study
por: Zhong, Linda Li-Dan, et al.
Publicado: (2022)

Effect of surgical treatment on patients with stage T3 or T4 triple-negative breast cancer: a SEER-based retrospective observational study
por: Hu, Jie, et al.
Publicado: (2023)

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
por: Zhou, Qin, et al.
Publicado: (2023)

Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer
por: Lin, Po‐Han, et al.
Publicado: (2020)

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
por: Huang, Liang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1q391g8ou21uhjlcsfgb7ptrg6